Echinocandin antifungal drugs are the ‘workhorses’ of antifungal therapy in hospitals. The WHO has endorsed their importance by adding them to the 2021 Essential Medicines List for low and middle countries, for both adults and children. Initially launched in 2002 in Japan and USA, micafungin (Astellas) and caspofungin (Merck) were the first to market… Read more »